TABLE 4 Evidence Table: Controlled Epidemiological Studies—Vaccines and Allergic Disorders

Citation

Design

Population

Vaccines

Outcome Measures

Results

Comment

Contribution to Causality Argument

Wickens et al. (2001)

Case- control

233 cases with wheezing or asthma; 241 controls; ages 7–9 years (New Zealand)

DTP,* DT, polio, MMR, measles, BCG, HepB from medical records

Wheezing or asthma in last 12 months by proxy or self-report

Unadjusted ORs (95% CI):

DTP = 1.51 (0.77-2.97)

DT/DTP = 1.43 (0.69-2.96)

HepB = 0.72 (0.50-1.06)

Polio = 2.11 (0.90-4.90)

Measles/MMR = 1.52 (0.89-2.58)

MMR = 1.62 (1.06-2.47)

BCG = 1.23 (0.41-3.72)

Adjusted ORs (95% CI)

HepB = 0.66 (0.42-1.05)

Polio = 2.48 (0.83-7.41)

MMR = 1.43 (0.85-2.41)

Potential selection bias, exposure misclassification, or multiple comparisons

weak evidence relevant to causality; favors no effect of any vaccine

Hurwitz & Morgenstern (2000)

cross-sectional survey (NHAN ES III)

13,944 infants and children ages 2 months through 16 years (United States)

DTP* or tetanus, by proxy (information obtained from children’s parent or guardian)

history of physician-diagnosed asthma, hay fever; self-report of allergic reactions by proxy; atopy by skin testing with 10 allergens

Estimated Crude ORs (95% CI)/Adjusted ORs (95% CI) of DTP or tetanus vaccination on following

Asthma = 2.20 (0.70-6.84)/2.00 (0.59-6.74)

Hay fever = 1.21 (0.21-6.83)/ 0.82 (0.16-4.35)

Severe allergic reaction = 2.11 (9.42-10.45)/1.50 (0.33-6.89)

Any allergy/allergic reaction = 2.11 (0.81-5.49)/1.66 (0.67-4.14)

Sinusitis/sinus problems = 2.16 (0.77-6.06)/1.81 (0.69-4.71)

Wheezing/whistling = 1.03 (0.68- 1.57)/1.23 (0.78?1.95)

Nose & eye symptoms = 2.44

Study limitations included the following: cross-sectional design, recall bias; missing data on 2.4% of unvaccinated subjects; small number of unvaccinated children; lack of clinical information; selection bias for care-seeking behavior; unmeasured confounding; limited ability to control for con

weak evidence relevant to causality; favors effect of DTP or tetanus vaccine on clinical history of allergic disorder but no effect on atopy defined by skin test reactivity



The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement